C12N 2740/17022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2740/17022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 37 US grants and 25 published applications in this corpus.
Search patents in C12N- Granted patents
- 37
- Published applications
- 25
- Assignees
- 18
- Inventors
- 52
- Latest grant
- 21 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 8 | 0 |
| 2001 | 4 | 1 |
| 2002 | 3 | 0 |
| 2003 | 2 | 2 |
| 2004 | 4 | 3 |
| 2005 | 1 | 1 |
| 2006 | 1 | 0 |
| 2007 | 2 | 2 |
| 2008 | 0 | 1 |
| 2009 | 1 | 3 |
| 2010 | 1 | 2 |
| 2011 | 1 | 2 |
| 2012 | 3 | 2 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 2 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Foamy viruses and methods of use21 Jan 2025US 12,201,659 B2Mayo Foundation for Medical Education and Research
- Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use15 Sep 2015US 9,133,483 B2The Trustees of the University of Pennsylvania
- Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures21 Apr 2015US 9,012,618 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use10 Dec 2013US 8,603,459 B2The Trustees of the University of Pennsylvania
- Foamy viral envelope genes13 Nov 2012US 8,309,071 B2Vectoria Forschungsforderungs Verein E.V.
- Foamy viruses and methods of use3 Apr 2025US 2025/0108079 A1Mayo Foundation for Medical Education and Research
- Targeted retroviral integration for treatment of genetic disorders26 Dec 2024US 2024/0425828 A1Ohio State Innovation Foundation
- Foamy viruses and methods of use18 Feb 2021US 2021/0046134 A1Mayo Foundation for Medical Education and Research
- Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use4 May 2017US 2017/0119873 A9The Trustees of the University of Pennsylvania
- Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use10 Dec 2015US 2015/0352203 A1The Trustees of the University of Pennsylvania
Most cited
By later US patents
- Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use102US 7,247,472 B2The Trustees of the University of Pennsylavania · 2007
- Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use50US 8,105,574 B2The Trustees of the University of Pennsylvania · 2012
- Simian immunodeficiency virus peptides with antifusogenic and antiviral activities47US 6,017,536 ATrimeris, Inc. · 2000
- Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use46US 8,603,459 B2The Trustees of the University of Pennsylvania · 2013
- Compositions for inhibition of membrane fusion-associated events, including influenza virus transmission37US 6,060,065 ADuke University · 2000